These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 13444623)

  • 1. Atypical acid-fast bacilli. II. Mycobacterium fortuitum: bacteriologic characteristics and pathogenicity for laboratory animals.
    KUSHNER DS; MCMILLEN S; SENDERI M
    Am Rev Tuberc; 1957 Jul; 76(1):108-22. PubMed ID: 13444623
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Cole AL; Kirk NM; Wang L; Hung CC; Samuelson JP
    J Vet Diagn Invest; 2022 Jan; 34(1):116-120. PubMed ID: 34448422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on atypical acid-fast bacilli. (II) Virulence of atypical acid-fast bacilli.
    ADACHI K
    Sci Rep Res Inst Tohoku Univ Med; 1959 Dec; 9():25-33. PubMed ID: 13848734
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in the kidneys in patients with successive findings of Mycobacterium xenopi and Mycobacterium fortuitum in the urine--report of 16 cases]].
    Lovodić-Sivcev B; Vukelić A
    Med Pregl; 1999; 52(9-10):334-42. PubMed ID: 10624381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenicity of Mycobacterium fortuitum and Mycobacterium smegmatis to goldfish, Carassius auratus.
    Talaat AM; Trucksis M; Kane AS; Reimschuessel R
    Vet Microbiol; 1999 Apr; 66(2):151-64. PubMed ID: 10227476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nontuberculous Mycobacteria: Skin and Soft Tissue Infections.
    Gonzalez-Santiago TM; Drage LA
    Dermatol Clin; 2015 Jul; 33(3):563-77. PubMed ID: 26143432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the virulence of atypical acid-fast bacilli. (On the fate of viable bacilli and the pathological changes in organs of mice intravenously infected with various types of atypical acid-fast bacilli].
    SOMEYA S; HAYASHI O; EGASHIRA Y; OGAWA Y
    Nihon Saikingaku Zasshi; 1962 May; 17():376-82. PubMed ID: 13915101
    [No Abstract]   [Full Text] [Related]  

  • 8. [Consideration on the virulence of atypical acid-fast bacilli. The fate of the living bacilli in the host by the homogenization of the whole body of the mouse].
    OSHIMA K
    Kekkaku; 1960 Mar; 35():201-5. PubMed ID: 14429217
    [No Abstract]   [Full Text] [Related]  

  • 9. Differentiation of human tubercle bacilli from atypical acid-fast bacilli. I. Niacin production of human tubercle bacilli and atypical acid-fast bacilli.
    KONNO K; KURZMANN R; BIRD KT; SBARRA A
    Am Rev Tuberc; 1958 Apr; 77(4):669-74. PubMed ID: 13521262
    [No Abstract]   [Full Text] [Related]  

  • 10. Mycobacterium fortuitum-induced persistent parotitis: successful therapy with clarithromycin and ciprofloxacin.
    Chen CC; Chen SY; Chen YS; Lo CY; Cheng PW
    Head Neck; 2007 Nov; 29(11):1061-4. PubMed ID: 17427970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium fortuitum pneumonia in a cat and the role of lipid in the pathogenesis of atypical mycobacterial infections.
    Couto SS; Artacho CA
    Vet Pathol; 2007 Jul; 44(4):543-6. PubMed ID: 17606521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nontuberculous mycobacteria: susceptibility pattern and prevalence rate in Shanghai from 2005 to 2008.
    Wang HX; Yue J; Han M; Yang JH; Gao RL; Jing LJ; Yang SS; Zhao YL
    Chin Med J (Engl); 2010 Jan; 123(2):184-7. PubMed ID: 20137367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventriculoperitoneal shunt infection with Mycobacterium fortuitum: a rare offending organism.
    Cadena G; Wiedeman J; Boggan JE
    J Neurosurg Pediatr; 2014 Dec; 14(6):704-7. PubMed ID: 25325413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid means of differentiating atypical acid-fast bacilli and avian tubercle bacilli from other mycobacteria; the neotetrazolium inhibition test.
    GASTAMBIDE-ODIER M; SMITH DW
    Am Rev Tuberc; 1958 Apr; 77(4):662-8. PubMed ID: 13521261
    [No Abstract]   [Full Text] [Related]  

  • 15. Murine infection model for Mycobacterium fortuitum.
    Parti RP; Srivastava S; Gachhui R; Srivastava KK; Srivastava R
    Microbes Infect; 2005 Mar; 7(3):349-55. PubMed ID: 15777648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nontuberculous mycobacteria pathogenesis and biofilm assembly.
    Sousa S; Bandeira M; Carvalho PA; Duarte A; Jordao L
    Int J Mycobacteriol; 2015 Mar; 4(1):36-43. PubMed ID: 26655196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of human tubercle bacilli from atypical acid-fast bacilli. II. Clinical application.
    KONNO K; KURZMANN R; BIRD KT; SBARRA A
    Am Rev Tuberc; 1958 Apr; 77(4):675-80. PubMed ID: 13521263
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the pathogenicity of atypical Mycobacteria for guinea pigs and mice].
    USHIBA D; OZAWA A; NAKAYAMA S; UJIIE A
    Kekkaku; 1961 Nov; 36():689-93. PubMed ID: 13923966
    [No Abstract]   [Full Text] [Related]  

  • 19. A transposon insertion mutant of Mycobacterium fortuitum attenuated in virulence and persistence in a murine infection model that is complemented by Rv3291c of Mycobacterium tuberculosis.
    Parti RP; Shrivastava R; Srivastava S; Subramanian AR; Roy R; Srivastava BS; Srivastava R
    Microb Pathog; 2008; 45(5-6):370-6. PubMed ID: 18930129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frequency and clinical relevance of rapidly growing mycobacterium isolated from respiratory samples].
    Duan HF; Wang QF; Wang J; Wang J; Huang HR; Chu NH
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Feb; 39(2):113-6. PubMed ID: 26879615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.